For the first quarter 2013, analysts estimate SNTS will generate revenues of $74.7M, an increase of 62.80% over the prior year first quarter results. Analysts estimate SNTS will earn $0.14 per share, an increase of 1,320.00% over the prior year first quarter results. Second quarter will be higher and higher each quarter thereafter! GO SNTS!
Kitty, you are probably correct in lower 70's. I don't think Uceris may have had enough time to truly impact this qtr with only a little over a month of sales. The big # to watch out for over the course of the year that was mentioned in the Analyst trannscript will be any sales of Uceris over the 50 mil mark. That is the point when Uceris becomes highly profitable. 2nd qtr will probably give better insight, though a 1st qtr surprise would be great.
Kitty, though I agree with you, I would be very surprised if they don't get 80 or above. Going on that analyst transcript, it sounds like Management is very excited with the current progress of Uceris. Glumetza and especially Zegerid continue to make bigger strides every quarter. I realize it is an average game and I don't want to get my hopes up too high, but I would be somewhat surprised if they were 73. Now that I say this, however, with Uceris coming out in February, it has probably had minimal time to impact the quarter revenue, right?